eSyM Control Participants (Medical Oncology and Surgery Participants Combined) vs eSyM Intervention Participants (Medical Oncology and Surgery Participants Combined): deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.232 | 0.226 | 0.238 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.221 | 0.215 | 0.227 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.011 | 0.0028 | 0.0192 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.05 | 1.01 | 1.09 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 1.06 | 1.02 | 1.12 | log | ClinicalTrials.gov | |
Number needed to harm, for one more death from any cause on eSyM Control Participants (Medical Oncology and Surgery Participants Combined) than on eSyM Intervention Participants (Medical Oncology and Surgery Participants Combined) | 90.7 | 52 | 357 | from the risk difference interval | ClinicalTrials.gov |
Groups 2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | eSyM Control Participants (Medical Oncology and Surgery Participants Combined) | These patients (and/or proxy) were seen at a participating site prior to the trial rollout of eSyM and were not exposed to the eSyM intervention.~This group includes the following trial subsets:~* patients NOT exposed to the eSyM intervention through the stepped wedge cluster randomized trial (control cohort)~* patients participating in the SASS control questionnaire | 4,898 | 21,112 | EG000 | ClinicalTrials.gov |
| Group 2 | eSyM Intervention Participants (Medical Oncology and Surgery Participants Combined) | These patients (and/or proxy) were seen at a participating site after the trial rollout of eSyM and were exposed to the eSyM intervention.~This group includes the following trial subsets:~* patients exposed to the eSyM intervention through the stepped wedge cluster randomized trial (intervention cohort)~* patients participating in the SASS intervention questionnaire~* patients participating in qualitative interviews~* patients participating in pilot testing | 4,161 | 18,830 | EG001 | ClinicalTrials.gov |
Harm 2
| Field | Value | Source |
|---|---|---|
| What it counts | Total, all-cause mortality | ClinicalTrials.gov |
| Time frame | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Symptom Management Implementation of Patient Reported Outcomes in Oncology | ClinicalTrials.gov |
| NCT number | NCT03850912 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Other Cancer, Gastrointestinal Cancer, Thoracic Cancer, Gynecologic Cancer | ClinicalTrials.gov |
| Interventions | Stakeholder Survey (Control Period), Stakeholder Survey (Intervention Period), Qualitative Interview, SASS Questionnaire, eSyM | ClinicalTrials.gov |
| Lead sponsor | Dana-Farber Cancer Institute | ClinicalTrials.gov |
| Results first posted | 2025-08-27 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT03850912?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.